Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 062538/0962 | |
| Pages: | 3 |
| | Recorded: | 01/27/2023 | | |
Attorney Dkt #: | 51012-023002 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
2
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16648408
|
Filing Dt:
|
03/18/2020
|
Publication #:
|
|
Pub Dt:
|
09/03/2020
| | | | |
Title:
|
BIOREDUCTIVELY-ACTIVATED COMPOUNDS, THEIR PRODRUGS, RADIOPHARMACEUTICALS, THE COMPOSITIONS, AND THEIR APPLICATIONS IN MULTIMODAL THERANOSTIC MANAGEMENT OF HYPOXIA DISEASES INCLUDING CANCER
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17725271
|
Filing Dt:
|
04/20/2022
|
Publication #:
|
|
Pub Dt:
|
08/11/2022
| | | | |
Title:
|
BIOREDUCTIVELY-ACTIVATED COMPOUNDS, THEIR PRODRUGS, RADIOPHARMACEUTICALS, THE COMPOSITIONS, AND THEIR APPLICATIONS IN MULTIMODAL THERANOSTIC MANAGEMENT OF HYPOXIA DISEASES INCLUDING CANCER
|
|
Assignee
|
|
|
6030 - 88TH STREET |
#103 |
EDMONTON, CANADA T6E 6G4 |
|
Correspondence name and address
|
|
CLARK+ELBING LLP
|
|
101 FEDERAL STREET
|
|
15TH FLOOR
|
|
BOSTON, MA 02110
|
Search Results as of:
06/21/2024 08:06 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|